Aliskiren hemifumarate and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Aliskiren hemifumarate (aliskiren hemifumarate), especially for people who are female, 60+ old, also take Aspirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Weakness when taking Aliskiren hemifumarate. It is created by eHealthMe based on reports of 157 people who have side effects when taking Aliskiren hemifumarate from the FDA, and is updated regularly.

What is Aliskiren hemifumarate?

Aliskiren hemifumarate has active ingredients of aliskiren hemifumarate. eHealthMe is studying from 159 Aliskiren hemifumarate users. Check the latest studies of Aliskiren hemifumarate.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Apr, 29, 2026

157 people reported to have side effects when taking Aliskiren hemifumarate.
Among them, 125 people (79.62%) have Weakness.

Could Aliskiren hemifumarate cause Weakness?

Among these 125 people:

What is the gender of people who have Weakness when taking Aliskiren hemifumarate? *

Click here to view

What is the age of people who have Weakness when taking Aliskiren hemifumarate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Aliskiren hemifumarate and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aliskiren hemifumarate:

Aliskiren hemifumarate (159 reports)

Weakness treatments and more:

Weakness (586,876 reports)

How severe was Weakness and when was it recovered:

Weakness in Aliskiren hemifumarate

Expand to all the drugs that have ingredients of aliskiren hemifumarate:

Weakness and drugs with ingredients of aliskiren hemifumarate (1,239 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aliskiren hemifumarate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate (the active ingredients of Aliskiren hemifumarate) and Aliskiren hemifumarate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.